These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 294215

  • 1. Fiber dimensions and aspect ratio of crocidolite, chrysotile and amosite particles detected in lung tissue specimens.
    Pooley FD, Clark N.
    Ann N Y Acad Sci; 1979; 330():711-6. PubMed ID: 294215
    [Abstract] [Full Text] [Related]

  • 2. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec.
    Dufresne A, Harrigan M, Massé S, Bégin R.
    Am J Ind Med; 1995 Apr; 27(4):581-92. PubMed ID: 7793429
    [Abstract] [Full Text] [Related]

  • 3. Analysis of asbestos fibers in lung parenchyma, pleural plaques, and mesothelioma tissues of North American insulation workers.
    Kohyama N, Suzuki Y.
    Ann N Y Acad Sci; 1991 Dec 31; 643():27-52. PubMed ID: 1809139
    [Abstract] [Full Text] [Related]

  • 4. Asbestos in the lungs of persons exposed in the USA.
    Langer AM, Nolan RP.
    Monaldi Arch Chest Dis; 1998 Apr 31; 53(2):168-80. PubMed ID: 9689804
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Evaluation of the exposure, dose-response and fate in the lung and pleura of chrysotile-containing brake dust compared to TiO2, chrysotile, crocidolite or amosite asbestos in a 90-day quantitative inhalation toxicology study - Interim results Part 1: Experimental design, aerosol exposure, lung burdens and BAL.
    Bernstein DM, Toth B, Rogers RA, Kling DE, Kunzendorf P, Phillips JI, Ernst H.
    Toxicol Appl Pharmacol; 2020 Jan 15; 387():114856. PubMed ID: 31836523
    [Abstract] [Full Text] [Related]

  • 10. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans.
    Garabrant DH, Pastula ST.
    Toxicol Appl Pharmacol; 2018 Dec 15; 361():127-136. PubMed ID: 30077661
    [Abstract] [Full Text] [Related]

  • 11. Asbestos body formation in the human lung: distinctions, by type and size.
    Murai Y, Kitagawa M, Hiraoka T.
    Arch Environ Health; 1995 Dec 15; 50(1):19-25. PubMed ID: 7717765
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Asbestos fiber analysis in seven asbestosis cases.
    Murai Y, Kitagawa M, Yasuda M, Okada E, Koizumi F, Miwa A.
    Arch Environ Health; 1994 Dec 15; 49(1):67-72. PubMed ID: 8117151
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Fiber burden and patterns of asbestos-related disease in workers with heavy mixed amosite and chrysotile exposure.
    Churg A, Vedal S.
    Am J Respir Crit Care Med; 1994 Sep 15; 150(3):663-9. PubMed ID: 8087335
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.